These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A de novo missense mutation in SLC12A5 found in a compound heterozygote patient with epilepsy of infancy with migrating focal seizures. Saito T; Ishii A; Sugai K; Sasaki M; Hirose S Clin Genet; 2017 Dec; 92(6):654-658. PubMed ID: 28477354 [TBL] [Abstract][Full Text] [Related]
8. A novel pathogenic Järvelä V; Hamze M; Komulainen-Ebrahim J; Rahikkala E; Piispala J; Kallio M; Kangas SM; Nickl T; Huttula M; Hinttala R; Uusimaa J; Medina I; Immonen EV Front Mol Neurosci; 2024; 17():1372662. PubMed ID: 38660387 [TBL] [Abstract][Full Text] [Related]
9. Potentiating KCC2 activity is sufficient to limit the onset and severity of seizures. Moore YE; Deeb TZ; Chadchankar H; Brandon NJ; Moss SJ Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10166-10171. PubMed ID: 30224498 [TBL] [Abstract][Full Text] [Related]
10. A noninvasive optical approach for assessing chloride extrusion activity of the K-Cl cotransporter KCC2 in neuronal cells. Ludwig A; Rivera C; Uvarov P BMC Neurosci; 2017 Jan; 18(1):23. PubMed ID: 28143398 [TBL] [Abstract][Full Text] [Related]
14. A variant of KCC2 from patients with febrile seizures impairs neuronal Cl- extrusion and dendritic spine formation. Puskarjov M; Seja P; Heron SE; Williams TC; Ahmad F; Iona X; Oliver KL; Grinton BE; Vutskits L; Scheffer IE; Petrou S; Blaesse P; Dibbens LM; Berkovic SF; Kaila K EMBO Rep; 2014 Jun; 15(6):723-9. PubMed ID: 24668262 [TBL] [Abstract][Full Text] [Related]
15. Reduced Efficacy of the KCC2 Cotransporter Promotes Epileptic Oscillations in a Subiculum Network Model. Buchin A; Chizhov A; Huberfeld G; Miles R; Gutkin BS J Neurosci; 2016 Nov; 36(46):11619-11633. PubMed ID: 27852771 [TBL] [Abstract][Full Text] [Related]
16. Identification of KCC2 Mutations in Human Epilepsy Suggests Strategies for Therapeutic Transporter Modulation. Duy PQ; David WB; Kahle KT Front Cell Neurosci; 2019; 13():515. PubMed ID: 31803025 [TBL] [Abstract][Full Text] [Related]
17. CIP1 is an activator of the K+-Cl- cotransporter KCC2. Wenz M; Hartmann AM; Friauf E; Nothwang HG Biochem Biophys Res Commun; 2009 Apr; 381(3):388-92. PubMed ID: 19232517 [TBL] [Abstract][Full Text] [Related]
18. Preclinical insights into therapeutic targeting of KCC2 for disorders of neuronal hyperexcitability. Duy PQ; He M; He Z; Kahle KT Expert Opin Ther Targets; 2020 Jul; 24(7):629-637. PubMed ID: 32336175 [TBL] [Abstract][Full Text] [Related]
19. Anomalous levels of Cl- transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex. Conti L; Palma E; Roseti C; Lauro C; Cipriani R; de Groot M; Aronica E; Limatola C Epilepsia; 2011 Sep; 52(9):1635-44. PubMed ID: 21635237 [TBL] [Abstract][Full Text] [Related]
20. Human and murine phenotypes associated with defects in cation-chloride cotransport. Delpire E; Mount DB Annu Rev Physiol; 2002; 64():803-43. PubMed ID: 11826289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]